Get the Stockscreener App
54.28
0.54%
0.29
After Hours:
54.15
-0.13
-0.24%
Centene Corp stock is traded at $54.28, with a volume of 5.44M.
It is up +0.54% in the last 24 hours and down -3.83% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$53.99
Open:
$53.83
24h Volume:
5.44M
Relative Volume:
1.18
Market Cap:
$27.62B
Revenue:
$163.07B
Net Income/Loss:
$3.31B
P/E Ratio:
8.6987
EPS:
6.24
Net Cash Flow:
$-490.00M
1W Performance:
+1.65%
1M Performance:
-3.83%
6M Performance:
-10.40%
1Y Performance:
-18.13%
1-Day Range:
$53.19
$54.31
1-Week Range:
$53.19
$55.15
52-Week Range:
$52.93
$80.59
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
54.28 | 27.62B | 163.07B | 3.31B | -490.00M | 6.24 |
|
UNH
Unitedhealth Group Inc
|
311.97 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
388.96 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
330.58 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
68.98 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
244.48 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Is Centene Co. (NYSE:CNC) a Core Component of NYSE Composite Healthcare Services? - Kalkine Media
Should Value Investors Buy Centene (CNC) Stock? - Yahoo Finance
Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target. - Insider Monkey
Morgan Stanley Initiates Centene (CNC) with Overweight Rating, Sets $70 PT - Insider Monkey
Centene’s SWOT analysis: stock faces challenges amid growth potential - Investing.com
Centene (CNC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Here's Why Centene (CNC) Could be Great Choice for a Bottom Fisher - Yahoo Finance
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today - Benzinga
Centene Stock: Is CNC Outperforming The Health Care Sector? - Barchart.com
Centene Stock: Is CNC Outperforming the Health Care Sector? - The Globe and Mail
Centene (CNC) Initiated with Overweight Rating by Morgan Stanley | CNC Stock News - GuruFocus
Morgan Stanley Sees Upside for Centene (CNC) Despite Policy Chal - GuruFocus
Centene Co. (NYSE:CNC) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
July 25th Options Now Available For Centene (CNC) - Nasdaq
WellCare of Ky adds supports for communities hit by tornadoes - Lane Report
Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer - Yahoo Finance
Centene Sees Unusually Large Options Volume (NYSE:CNC) - Defense World
Health Net Providing Special Assistance to Members and Providers Affected by Victoria Island Levee Incident in San Joaquin County, California - Quantisnow
Justice-Involved Individuals Reentering Society in Sacramento County Find a Place to Call Home Through a $2.6M Grant from Health Net to 'Break the Cycle' - Quantisnow
Centene Corp (CNC) Shares Down 3.3% on Jun 2 - GuruFocus
Barclays Downgrades Centene (CNC) on Policy Risk, Cuts Price Target to $65 - Insider Monkey
Centene (CNC) Target Price Cut by Barclays, Downgraded to Equal-Weight | CNC Stock News - GuruFocus
Breaking Down Centene: 5 Analysts Share Their Views - Benzinga
Barclays Lowers Centene (CNC) Stock Outlook Amid Concerns | CNC - GuruFocus
Are Investors Undervaluing Centene (CNC) Right Now? - Yahoo Finance
Health Net and Centene Corporation (CNC) Commit Over $7.2 Million to Boost Healthcare Access Through Mobile Clinics in California - Yahoo Finance
Health Net and Centene Foundation Invest More than $7.2 Million to Increase Patient Access to Care with Expanded Fleet of Mobile Clinics in California – Company AnnouncementFT.com - Financial Times
Zacks Investment Ideas feature highlights: Netflix, Eaton and Centene - The Globe and Mail
St. Louis’ Public Companies Show Strength - stl.news
Centene’s SWOT analysis: stock outlook amid healthcare sector challenges - Investing.com
House Advances Trump's 'One Big Beautiful Bill' After Key Medicaid, Tax, And Border Security Changes - Benzinga
Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses - Benzinga
The Zacks Analyst Blog Highlights UnitedHealth, Centene and Molina Healthcare - TradingView
Factors That Make Centene Stock a Lucrative Pick Right Now - Nasdaq
Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses - Benzinga
Zacks Value Trader Highlights: Centene, Copa and KB Financial - TradingView
Q1 Rundown: Centene (NYSE:CNC) Vs Other Health Insurance Providers Stocks - Yahoo Finance
Cantor Fitzgerald maintains Overweight on Centene shares, $90 target - Investing.com
Insider Stock Buying Reaches US$3.27m On Centene - Yahoo Finance
Screening for Basic Value Stocks - TradingView
Centene shareholders reject climate-related proposals in annual meeting vote - The Business Journals
Sarah London: Leading Women 2025 - Modern Healthcare
Sarah London named Modern Healthcare's Leading Women Vanguard - Modern Healthcare
Sarah London named Modern Healthcare’s Women Leaders Vanguard - Modern Healthcare
Centene Corporation (CNC) Announces Results of Annual Meeting - GuruFocus
Centene shareholders vote on key proposals at annual meeting - Investing.com
Here's Why Centene (CNC) is a Strong Value Stock - Yahoo Finance
Why Centene Corporation (CNC) Declined on Tuesday - Insider Monkey
Massive Sell-Offs Just Hit These 10 Stocks Today - Insider Monkey
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period - Stock Titan
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Centene Corp Stock (CNC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Greco Thomas | Director |
Dec 18 '24 |
Buy |
59.75 |
17,000 |
1,015,750 |
19,309 |
| Dallas H James | Director |
Dec 16 '24 |
Buy |
59.01 |
1,693 |
99,904 |
1,693 |
| BLUME JESSICA L. | Director |
Dec 16 '24 |
Buy |
59.48 |
250 |
14,870 |
250 |
| COUGHLIN CHRISTOPHER J | Director |
Dec 16 '24 |
Buy |
59.44 |
10,000 |
594,400 |
36,358 |
| Samuels Theodore R. II | Director |
Dec 13 '24 |
Buy |
58.86 |
5,000 |
294,300 |
23,000 |
| Asher Andrew Lynn | Chief Financial Officer |
Nov 13 '24 |
Buy |
58.14 |
17,200 |
1,000,008 |
486,847 |
| LONDON SARAH | Chief Executive Officer |
Nov 08 '24 |
Buy |
60.80 |
4,117 |
250,314 |
667,229 |
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):